pharma pharma-s-back-to-work-plans-2021 
pharmaphorum
NOVEMBER 25, 2020
Trio Health’s Neil McGregor-Paterson asks whether the healthcare industry has paid enough attention to the patient voice during COVID-19 and looks at the many ways pharma can improve the patient experience across the sector going forward. All with a speed and agility that could never be replicated by providers.
pharmaphorum
MAY 16, 2022
USAID is an influential leader in the COVID-19 digital health response, and Waugaman had a significant part in developing the agency’s first two digital health policies adopted by countries globally.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 5, 2021
Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it to the top of the world’s biggest-selling medicines. . The sales forecast for 2021 is based on contracts to deliver 1.6 billion doses of the shot this year, but Pfizer is planning to produce 2.5
ISPE
NOVEMBER 2, 2022
The gavel passed to a new International Board Chair and ISPE leaders shared 2022 achievements and plans for 2023 at the 2022 ISPE Membership Meeting and Awards Lunch. Vetter Pharma-Fertigung GmbH & Co. opened the Membership Meeting with a look back at the year. “A One ISPE initiative is a work in progress, he said.
pharmaphorum
NOVEMBER 1, 2022
Eli Lilly’s links to Purdue University go back a long way, and have been reinvigorated with $92.5 The new funding will establish a new pharmaceutical manufacturing scholarship programme – backed with $42.5 The university spent around $19 million on biopharma research in 2021.
pharmaphorum
JANUARY 31, 2022
Pfizer has called time on its alliance with Ionis for cholesterol-lowering therapy vupanorsen, after a review of phase 2b data raised some questions about the antisense drug’s efficacy and safety. billion at the back end in milestone payments, but will now return rights to Ionis.
pharmaphorum
MARCH 8, 2022
In October 2021, I joined the engineering department at Envair Technology, designing isolators. I was encouraged instead to use my interest in science and study medicine, and I trained to be a hospital doctor at King’s College London. What has your career path been? How did you get into life sciences?
Expert insights. Personalized for you.
114 
Let's personalize your content